Epilepsy trials in South Korea

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  Where

  Daegu, Seoul

  Age

  4 years to 55 years

  People

  252 worldwide

  Run by

  SK Life Science, Inc.

  See details and how to joinNCT05219617
• Phase 3Taking people
  Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  Where

  Busan, Seoul

  Age

  18 years to 75 years

  People

  333 worldwide

  Run by

  Rapport Therapeutics Inc.

  See details and how to joinNCT07563881
• No phaseNot yet taking people in South Korea
  Electrophysiological Dose-Response to Anterior Thalamic Deep Brain Stimulation in Drug-Resistant Focal Epilepsy

  Where

  Seoul

  Age

  19 years and over

  People

  10

  Run by

  Yonsei University

  See details and how to joinNCT07912931
• Phase 3Not yet taking people in South Korea
  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  Where

  Seoul

  Age

  2 years and over

  People

  438 worldwide

  Run by

  Yale University

  See details and how to joinNCT07281027